Since the onset of the COVID-19 pandemic in the fall of 2019 over 4 million people have been infected and over 280,000 have died (1). Information about the SARS-CoV2 virus is evolving rapidly. At this time there are no interventions proven to be effective for cases infected with SARS-CoV2. Current knowledge about the clinical and laboratory manifestations of COVID-19 infection is reviewed and combined with knowledge about the immunopathogenic mechanisms of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV1) and Middle East Respiratory Syndrome (MERS) to formulate theories and suggest possible therapeutic interventions. SARS-CoV2 immunopathogenic mechanisms vary from immunosuppression that initially enables viral escape to a hyperinflammatory immune response. Ultimately therapeutic intervention will be phase dependent.


  • Infection
  • Asymptomatic
  • Symptomatic
  • AIDS/Progression of HIV to AIDS

Related Conference of Immunopathogenesis

March 18-19, 2021

3rd World Conference on Vaccine and Immunology

Dubai, UAE
March 24-24, 2021

3rd International Conference on Dermatology and Allergic Diseases

Singapore City, Singapore
April 15-16, 2021

Tumor & Cancer Immunology and Pediatric-Oncology

Toronto, Canada
April 19-20, 2021

9th World Summit on immunology & immunotherapy

Prague, Czech Republic
May 03-04, 2021

International Online Conference on Immunology

New York, USA
June 23-24, 2021

34th World Congress on Vaccines and Immunization

Osaka, Australia
October 12-13, 2021

International Conference on Vaccine and Vaccine research

Manila, Philippines
October 14-15, 2021

13th Annual Conference on Cinical Immunology

Cape Town, Australia
October 14-15, 2021

11th International Conference on Bacteriology and Infectious Diseases

Cape Town, South Africa

Immunopathogenesis Conference Speakers

Recommended Sessions

Related Journals

Are you interested in